openPR Logo
Press release

The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In U.S. Market

09-03-2018 07:56 PM CET | Health & Medicine

Press release from: Precision Business Insights

U.S. Influenza market

U.S. Influenza market

Influenza is an upper respiratory tract disease and is caused by the Influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children with less than 5 years of age. The infection may be confirmed by testing the sputum, nose, or throat for the virus. A number of rapid tests are available however polymerase chain reaction that detects the virus’s RNA is more accurate.
The U.S. Influenza market is growing at a significant rate owing to rise in newborn babies, an increase in geriatric population. Increase in vaccination awareness, favorable reimbursement policies, and rising investment by companies in R & D activities are the major factors propelling the growth of U.S. influenza market. The major market players have many pipeline products, initiatives by government bodies such as WHO and CDC to control and prevent influenza, technological advancements in diagnostic tests also fuel the growth of U.S. influenza market. However, limited production capacity, a high level of required investment, and stringent regulatory policies for new product approvals might hamper the growth of U.S. Influenza market. Due to limitations in current technologies, the lengthy production times (approximately seven months), increase in prices of influenza diagnostic kits and reagents also hinder the Influenza vaccines market.
The U.S. Influenza market is divided into following categories-
1. Drug class
• Anti-viral drugs
o Zanamivir
o Oseltamivir
o Amantadine
o Rimantadine
o Others
o Interferons
• Vaccines
o Trivalent
o Quadrivalent
2. Route of administration
• Oral
• Parenteral
• Others
3. End- users
Hospital pharmacies, retail pharmacies and others.
U.S. holds a strong position in the global influenza vaccine market. The largest share is attributed to the higher rate of in-vitro diagnostics availability and technological advancements in medical devices which are primarily driving the U.S. Influenza diagnostic market growth. As per CDC, person above 6 months of age could be vaccinated to prevent the influenza infection. Increase in prevalence and incidence cases of influenza might increase the growth of U.S. influenza vaccine market. Similarly, the increase in funding by the government is also driving the market growth in the United States.
Some of the key players in U.S. influenza therapeutics market are AstraZeneca (U.K.), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Seqirus (U.K.), Protein Sciences Corporation (U.S.), Emergent Biosolutions (U.S.), Alvogen (South Korea), DynPort Vaccine Company, LLC. (U.S.), and Abbott Laboratories (U.S.) to name a few. In 2016, Seqirus received approval from USFDA for Flucelvax Quadrivalent, that was the first U.S. licensed cell-based quadrivalent influenza vaccine indicated for people aged four years and older. While in the same year, GSK received approval from USFDA for Flulaval Quadrivalent to include use in children aged six months or older.
Influenza vaccines are key revenue contributor for the growth of U.S. influenza vaccine market. The U.S. influenza diagnostic market is in growing phase, several international players are actively involved in the development of vaccines and drugs to treat influenza. The launch of new products, technological innovations, and approvals from U.S. (FDA) for various drugs might fuel the growth of U.S. influenza therapeutics market. For instance, transformative changes in other vaccine markets, due to the entrance of expensive and innovative vaccines such as Gardasil (Merck) and Bexsero (GSK) are projected to contribute growth of the U.S. influenza diagnostic market.

For More Information:https://www.precisionbusinessinsights.com/market-reports/u-s-influenza-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In U.S. Market here

News-ID: 1217462 • Views: 485

More Releases from Precision Business Insights

Canada Cardiovascular Devices Market Key Developments Forecast 2022 To 28
The canada cardiovascular devices market size was valued at USD x billion in 2021, growing at a CAGR of 4.0% during the forecast period 2022 to 2028. Cardiovascular devices are a broad category of medical equipment used to diagnose and treat heart conditions and other related health issues. They are made to support surgical operations and illness monitoring. Stents, heart valves, grafts, catheters, electrocardiogram (ECG), remote cardiac monitoring, and cardiac
Canada Drug-Coated Balloons Market Size, Growth Strategies 2022-28
The canada drug-coated balloons market size was valued at USD x billion in 2021, growing at a CAGR of 11.9% during the forecast period 2022 to 2028. Anti-proliferative medications are coated on one or both sides of semi-compliant angioplasty balloons known as drug-coating balloons. The balloons are distributed across the blood vessel walls after inflation, which is typically done at low pressures. These balloons greatly minimize cellularity and do away
Fiberglass Market Demand And Growth Analysis 2022-28
The global fiberglass market size was valued at USD 11.5 billion in 2021, growing at a CAGR of 5.1% during the forecast period 2022 to 2028. A reinforced plastic substance comprised of glass fibers enmeshed in a resin matrix is referred to as fiberglass. Glass wool, direct and assembled roving, yarn, chopped strands, flattened sheets, etc. are all common forms in which it is offered. Fiberglass offers great electrical insulation
In-vitro Toxicology Market Size | Share | Industry Analysis 2022-2028
The global in-vitro toxicology market size was valued at USD 10.2 billion in 2021 and is poised to grow at a significant CAGR of 11.1% during the forecast period 2022-28. Testing for in-vitro toxicity is a method for identifying potentially dangerous compounds. Additionally, it is employed to ascertain the presence of particular harmful properties in beneficial substances, such as agricultural pesticides, therapeutic medications, and food additives. Toxicology testing is essential

All 5 Releases


More Releases for Influenza

H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,
Influenza Vaccine Market | DPIResearch.com
According to the DPI Research new growth forecast report titled “Worldwide Influenza Vaccines Market Size | Forecast to 2027” to Witness Comprehensive Growth by 2027 DPI Research published a new report on Worldwide Influenza Vaccines Market. The research offers an extensive analysis of key players active in the Worldwide Influenza Vaccines Market. Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research.
Influenza Vaccines
Influenza Drugs and Vaccines Market describes its growth, size, share, Forecast and trends to 2025 Influenza Drugs and Vaccines Market Production and Demand Analysis 2019 to 2025 Influenza Drugs and Vaccines Market 2019 Manufacturing Analysis and Development Forecast 2025 Influenza Drugs and Vaccines Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Influenza Drugs and Vaccines Market to Insight By 2025: Top Key Vendors Influenza Drugs and Vaccines Market Insights 2019, Global and
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In European Ma …
Europe Influenza Market Influenza is an upper respiratory tract disease and is caused by the influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children less than five years of age. The infection may be confirmed by testing
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Rise in Prevalence of Influenza Infections Drives the Influenza Medication Marke …
Influenza, commonly known as “flu,” is a respiratory disorder caused by an influenza virus. It is an infectious disorder which is of three types: type A, type B, and type C. The common symptoms of the disorder are cough, cold, fever, and sore throat, which can be mild or severe. The disease is spread easily from person to person by sneezing, coughing, or touching surfaces, and is generally diagnosed on